These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37106259)

  • 21. Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with Moyamoya disease: a prospective cohort study.
    Zhang B; Li J; Zeng C; Tao C; He Q; Liu C; Zheng Z; Zhao Z; Mou S; Sun W; Wang J; Zhang Q; Wang R; Zhang Y; Ge P; Zhang D
    Lipids Health Dis; 2024 Mar; 23(1):80. PubMed ID: 38494486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct versus indirect bypasses for adult ischemic-type moyamoya disease: a propensity score-matched analysis.
    Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Liu X; Zhang Q; Zhao J
    J Neurosurg; 2018 Jun; 128(6):1785-1791. PubMed ID: 28799875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage.
    Li Y; Liu X; Chen S; Wang J; Pan C; Li G; Tang Z
    CNS Neurosci Ther; 2023 Jun; 29(6):1484-1496. PubMed ID: 36942509
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study.
    Yoo J; Jeon J; Baik M; Kim J
    Stroke Vasc Neurol; 2023 Aug; 8(4):276-283. PubMed ID: 36549762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Hemorrhage-prone Anastomoses in Asymptomatic Moyamoya Disease-A Comparative Study with Japan Adult Moyamoya Trial.
    Yamamoto S; Funaki T; Fujimura M; Takahashi JC; Uchino H; Houkin K; Tominaga T; Miyamoto S; Kuroda S;
    J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104328. PubMed ID: 31471213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microembolic signals and antiplatelet therapy in Moyamoya angiopathy.
    Pompsch M; Veltkamp R; Diehl RR; Kraemer M
    J Neurol; 2022 Dec; 269(12):6605-6612. PubMed ID: 36002693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
    Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
    Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Surgery and Antiplatelet Therapy in Ten-Year Follow-Up from the Registry Study of Research Committee on Moyamoya Disease in Japan.
    Yamada S; Oki K; Itoh Y; Kuroda S; Houkin K; Tominaga T; Miyamoto S; Hashimoto N; Suzuki N;
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):340-9. PubMed ID: 26654669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
    Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Features, Surgical Treatment, and Long-Term Outcome in Children with Hemorrhagic Moyamoya Disease.
    Ge P; Zhang Q; Ye X; Wang S; Zhang D; Zhao J
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1517-1523. PubMed ID: 29567119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical effects of restarting antiplatelet therapy in patients with intracerebral hemorrhage.
    Jung NY; Cho J
    Clin Neurol Neurosurg; 2022 Sep; 220():107361. PubMed ID: 35835024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Prior Antiplatelet Therapy on the Prognosis of Primary Intracerebral Hemorrhage: A Meta-analysis.
    Yu HH; Pan C; Tang YX; Liu N; Zhang P; Hu Y; Zhang Y; Wu Q; Deng H; Li GG; Li YY; Nie H; Tang ZP
    Chin Med J (Engl); 2017 Dec; 130(24):2969-2977. PubMed ID: 29237930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.
    Kim T; Oh CW; Kwon OK; Hwang G; Kim JE; Kang HS; Cho WS; Bang JS
    J Neurosurg; 2016 Jun; 124(6):1788-93. PubMed ID: 26636391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of aneurysms in patients with moyamoya disease: a 10-year single-center experience.
    Ni W; Jiang H; Xu B; Lei Y; Yang H; Su J; Gu Y; Mao Y
    J Neurosurg; 2018 Jun; 128(6):1813-1822. PubMed ID: 28841118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of different surgical modalities on the clinical outcome of patients with moyamoya disease: a prospective cohort study.
    Deng X; Gao F; Zhang D; Zhang Y; Wang R; Wang S; Cao Y; Zhao Y; Pan Y; Ye X; Liu X; Zhang Q; Wang J; Yang Z; Zhao M; Zhao J
    J Neurosurg; 2018 May; 128(5):1327-1337. PubMed ID: 28686113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preoperative clinical symptomatology and stroke burden in pediatric moyamoya angiopathy: Defining associated risk variables.
    Hackenberg A; Battilana B; Hebeisen M; Steinfeld R; Khan N
    Eur J Paediatr Neurol; 2021 Nov; 35():130-136. PubMed ID: 34715507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benefits and risks of antiplatelet medication in hemodynamically stable adult moyamoya disease.
    Pang CH; Cho WS; Kang HS; Kim JE
    Sci Rep; 2021 Sep; 11(1):19367. PubMed ID: 34588601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of Stroke Risk Factors between Symptomatic and Asymptomatic Patients in a North American Moyamoya Disease Cohort.
    Kumar M; Larson A; Jabal MS; Rinaldo L; Savastano L; Lanzino G; Meyer F; Lehman V; Klaas J
    Cerebrovasc Dis Extra; 2022; 12(2):72-75. PubMed ID: 35588715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.